Skip to content
Search

Latest Stories

GPhC appoints five new Council members

GPhC appoints five new Council members

The new Council members will replace Jo Kember, Mark Hammond, Arun Midha, Elizabeth Mailey and Jayne Salt.

The General Pharmaceutical Council (GPhC) has announced the names of five new members who will be joining its governing Council over the next two years.


The new council members are:

  1. Professor Dianne Ford, Pro Vice-Chancellor of the Faculty of Health and Life Sciences at Northumbria University.
  2. Gareth Powell, a chartered accountant and a Non-Executive Director on the Board of the Port of Milford Haven, the UK’s largest energy port.
  3. Adeyemi (Ade) Williams MBE, Superintendent Pharmacist and Director of the M J Williams Pharmacy and lead Pharmacist at the Bedminster Pharmacy, Bristol.
  4. Tim Jaggard, Deputy Chief Executive and Chief Financial Officer at University College London Hospitals NHS Foundation Trust.
  5. Dr Raliat Onatade, Chief Pharmacist and Director of Medicines and Pharmacy for North-East London Integrated Care System.

Professor Ford, Powell and Williams will begin their terms on 1 April 2024, replacing Jo Kember, Mark Hammond and Arun Midha.

Jaggard and Dr Onatade will take over the charge from Elizabeth Mailey and Jayne Salt respectively on 1 April 2025.

Gisela Abbam, Chair of the GPhC, maintained that their Council members are drawn from the “widest possible talent pools” and that they bring with them different life experiences, ideas, and perspectives.

"There are significant developments impacting on pharmacy and pharmacy regulation and we have an ambitious programme of work ahead. I’m sure that our new members will help shape our strategic plans for the future and help patients and wider society to benefit from safe, effective and inclusive pharmacy care.

"I’d also like to thank our outgoing Council members for their hard work and dedication throughout their terms of office, and I wish them all the best for the future,” he said.

Know more about the new members  

Professor Ford is a Co-opted Governor at Northumbria Healthcare NHS Foundation Trust, Fellow of the Royal Society of Biology and a Fellow of the Physiological Society. She has also served on research and advisory panels for the Biotechnology and Biological Sciences Research Council.

Powell lives and works in Wales and has served in the private, public and voluntary sectors, including as Chief Operating Officer of BBC Cymru Wales from 2008 until 2023. He is also a Non-Executive Director of Green Ibex Ltd, a company that supports businesses in achieving their carbon reduction goals.

Ade is an independent prescriber, who also holds several Non-Executive and Trustee roles in healthcare, community and charitable organisations, including the Southern Health NHS Foundation Trust, the Self Care Forum Charity, the Bristol Cathedral Council and lately North Bristol NHS Trust.

de holds a number of Non-Executive and Trustee roles in healthcare, community and charitable organisations, including the Southern Health NHS Foundation Trust, the Self Care Forum Charity, the Bristol Cathedral Council and lately North Bristol NHS Trust.

Jaggard was appointed to the Board of University College London Hospitals NHS Foundation Trust in 2015, from the post of Deputy Finance Director.  He has previously held the finance lead role for North Central London integrated care system.

Dr Onatade is also the Group Chief Pharmacist at Barts Health NHS Trust and Chief Pharmacist for North Thames Genomic Medicine Service Alliance.  She is a fellow of the Royal Pharmaceutical Society.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less